Paul Smaltz, Senior Vice President of BASF Pharma Solutions, explains how the company acts as a strategic partner to the ...

SK pharmteco is a global CDMO, with locations in the US, EU, and South Korea. The company’s core capabilities center on small ...

As a part of PDA Week 2026, Christopher Lewis, Emoja Biopharma and president of the Mountain States PDA Chapter, reflects on ...

European Biotechs are utilizing AI and precision medicines to improve the personalized treatment of cardiovascular disease.

Financial terms include $40 million upfront for four programs, expansion options, and opt-out economics up to $535 million per program plus low double-digit royalties, totaling up to $2.1 billion.

Fernanda Onofre, PhD, explains how the dsm-firmenich ModulaSENSE® Bitter platform and the functional application of vitamins as excipients are revolutionizing drug palatability and performance. While ...

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses step 1 in adopting AI ...

FDA rejects Replimune's melanoma therapy despite breakthrough designation, raising urgent questions about regulatory ...

Andrew Chang and Steven Falcone, Novo Nordisk, explain how FDA-EU GMP mutual recognition and a robust internal signal process drive global regulatory compliance. Andrew Chang, senior Director for ...

Indirect data suggest oral semaglutide outperforms orforglipron on weight loss and tolerability, with patients also favoring its treatment profile.

Legacy web forms used for clinical trial recruitment, adverse event reporting, laboratory data collection, and regulatory ...

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking. The careful design and development of formulated oral drug products are key to ensuring ...